top of page

Enter CxO – your all-in-one solution to guide your startup through every step.

From early research to clinical trials, managing money, IT support, HR advice, legal help, and safeguarding your ideas – our services are designed just for you. We make it simple, tackling the unique challenges of your startup journey. With CxO, your path to success just got a whole lot smoother.

How can we help you?

Let's see how CxO can help a recently founded, by CEO and CSO, biotech startup that has achieved a groundbreaking feat by developing an innovative antiviral drug designed to combat a critical global health issue. 

CFO -Finance services

​We will create and manage the financial systems for the company by developing a robust financial infrastructure your startup needs, alleviating concerns related to taxes, financial statement preparation, financial reporting, internal control, HR-related activities and crucially, providing invaluable assistance with fundraising, notarial, and legal matters.

By entrusting these critical tasks to our expert team, CEO can sidestep potential headaches that may arise from improperly managed financial activities. Our goal is to enable the start-up's team to concentrate on propelling the business forward and generating tangible value for your shareholders. With our dedicated financial support, you can navigate the complexities of financial management with confidence, ensuring a solid foundation for sustainable growth. Now you are in good hands to start developing your innovative antiviral drug, so lets start.

COO - manufacturing

The drug has shown promising results in early-stage trials, and the startup is gearing up for the challenges of drug manufacturing.

​Our Chief Operating Officer (COO) can help you with:

  1. Scale-up Challenges: The startup is transitioning from small-scale laboratory production to large-scale manufacturing to meet the demand for clinical trials and potential future commercialization. Scaling up a manufacturing process while maintaining product consistency and quality poses a significant challenge.

  2. Regulatory Compliance: Ensuring compliance with strict regulatory standards set by health authorities is critical. The startup must navigate complex regulatory frameworks to obtain necessary approvals for large-scale production and distribution.

  3. Quality Control: Maintaining stringent quality control measures throughout the manufacturing process is imperative. Implementing robust quality assurance protocols ensures the consistency, purity, and safety of the drug.

  4. Cost-Efficiency: Balancing the need for cost-effective manufacturing with maintaining high-quality standards is a constant challenge. The startup must explore innovative approaches to optimize production costs without compromising product integrity.

CDO - Preclinical


Before advancing to clinical trials, the startup is focused on conducting thorough preclinical studies to assess the drug's safety, efficacy, and overall feasibility for further development.

Our Chief Development Officer (CDO) can help you with:​

  1. Study Design and Planning: Designing comprehensive preclinical studies that provide meaningful insights into the drug's safety and effectiveness requires careful planning. Determining appropriate animal models and study endpoints is crucial.

  2. Regulatory Compliance: Ensuring adherence to regulatory guidelines for preclinical studies is paramount. The startup must navigate regulatory requirements to design studies that meet the standards set by health authorities.

  3. Data Interpretation: Interpreting preclinical data accurately and drawing meaningful conclusions is a complex task. The startup must have skilled scientists and researchers capable of analyzing results and making informed decisions based on the data generated.

CMO - Clinical trials

The startup is now entering Phase I clinical trials to evaluate the drug's safety, dosage, and initial efficacy in humans.

Our Chief Medical Officer (CMO) can help you with:

  1. Clinical Trial Design: Designing a well-structured Phase I trial that provides meaningful data on the drug's safety profile and initial effectiveness requires careful consideration. Determining the appropriate dosage levels and study endpoints is critical

  2. Identify a Clinical Research Organizations (CROs): The startup may collaborate with CROs specializing in early-phase clinical trials to leverage their expertise in patient recruitment, trial design, and regulatory compliance

  3. Early Dialogue with Regulatory Agencies: Engaging in early and open communication with regulatory agencies helps the startup obtain guidance on trial design and ensures alignment with regulatory expectations, streamlining the approval process


Like what you see? Get in touch to learn more.

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

Thanks for submitting!

bottom of page